Overlapping deletion regions at 11q23 in myelodysplastic syndrome and chronic lymphocytic leukemia, characterized by a novel BAC probe set

Cancer Genetics and Cytogenetics

Volumn 153, Issue 2, 2004, Pages 151-157

  Siew Gek Lee, Ann ^a   Rudduck Sivaswaren, Christina ^b   Khun Hong Lie, Daniel ^a   Li Ming Chua, Constance ^a   Tien, Sim Leng ^b   Morsberger, Laura ^c   Griffin, Constance A ^c  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 11Q; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOLOGIC MALIGNANCY; HUMAN; MYELODYSPLASTIC SYNDROME; NUCLEIC ACID PROBE; PRIORITY JOURNAL;

CENTROMERE; CHROMOSOME DELETION; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 11; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MYELODYSPLASTIC SYNDROMES; SEQUENCE DELETION; TELOMERE; TRANSLOCATION, GENETIC;

EID: 9944227139     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.01.007     Document Type: Article

References (37)

1. Ziemin-van der Poel S., McCabe N.R., Gill H.J., Espinosa R. III, Patel Y., Harden A., Rubinelli P., Smith S.D., LeBeau M.M., Rowley J.D., Diaz M.O. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA. 88:1991;10735-10739
2. Rowley J.D. The role of chromosome translocations in leukemogenesis. Semin Hematol. 36:1999;59-72
3. Bernard O.A., Berger R. Location and function of critical genes in leukemogenesis inferred from cytogenetic abnormalities in hematologic malignancies. Semin Hematol. 37:2000;412-419
4. Ferrando A.A., Look A.T. Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin Hematol. 37:2000;381-395
5. Huret J.L., Dessen P., Bernheim A. An atlas of chromosomes in hematological malignancies. Example: 11q23 and MLL partners. Leukemia. 15:2001;987-989
6. Harbott J., Mancini M., Verellen-Dumoulin C., Moorman A.V., Secker-Walker L.M. Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. European 11q23 Workshop participants. Leukemia. 12:1998;823-827
7. Ibrahim S., Estey E.H., Pierce S., Glassman A., Keating M., O'Brien S., Kantarjian H.M., Albitar M. 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses. Am J Clin Pathol. 114:2000;793-797
8. Takeuchi S., Cho S.K., Seriu T., Koike M., Bartram C.R., Reiter A., Schrappe M., Takeuchi C., Taguchi H., Koeffler H.P. Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia. Oncogene. 18:1999;7387-7388
9. Bain B.J., Moorman A.V., Johansson B., Mehta A.B., Secker-Walker L.M. Myelodysplastic syndromes associated with 11q23 abnormalities. European 11q23 Workshop participants. Leukemia. 12:1998;834-839
10. Doneda L., Montillo M., Intropido L., Tedeschi A., Morra E., Larizza L. Interphase fluorescence in situ hybridization analysis of del(11)(q23) and del(17)(p13) in chronic lymphocytic leukemia. a study of 40 early-onset patients. Cancer Genet Cytogenet. 140:2003;31-36
11. Dohner H., Stilgenbauer S., Benner A., Leupolt E., Krober A., Bullinger L., Dohner K., Bentz M., Lichter P. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 343:2000;1910-1916
12. Monni O., Knuutila S. 11q deletions in hematological malignancies. Leuk Lymphoma. 40:2001;259-266
13. Dohner H., Stilgenbauer S., James M.R., Benner A., Weilguni T., Bentz M., Fischer K., Hunstein W., Lichter P. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood. 89:1997;2516-2522
14. Stilgenbauer S., Liebisch P., James M.R., Schroder M., Schlegelberger B., Fischer K., Bentz M., Lichter P., Dohner H. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. Proc Natl Acad Sci USA. 93:1996;11837-11841
15. Zhu Y., Monni O., El-Rifai W., Siitonen S.M., Vilpo L., Vilpo J., Knuutila S. Discontinuous deletions at 11q23 in B cell chronic lymphocytic leukemia. Leukemia. 13:1999;708-712
16. Mori N., Morosetti R., Hoflehner E., Lubbert M., Mizoguchi H., Koeffler H.P. Allelic loss in the progression of myelodysplastic syndrome. Cancer Res. 60:2000;3039-3042
17. Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel
18. Starostik P., Manshouri T., O'Brien S., Freireich E., Kantarjian H., Haidar M., Lerner S., Keating M., Albitar M. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Res. 58:1998;4552-4557
19. Stankovic T., Weber P., Stewart G., Bedenham T., Murray J., Byrd P.J., Moss P.A., Taylor A.M. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet. 353:1999;26-29
20. Bullrich F., Rasio D., Kitada S., Starostik P., Kipps T., Keating M., Albitar M., Reed J.C., Croce C.M. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res. 59:1999;24-27
21. Schaffner C., Stilgenbauer S., Rappold G.A., Dohner H., Lichter P. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood. 94:1999;748-753
22. Bevan S., Catovsky D., Marossy A., Matutes E., Popat S., Antonovic P., Bell A., Berrebi A., Gaminara E., Quabeck K., Ribeiro I., Mauro F.R., Stark P., Sykes H., van Dongen J., Wimperis J., Wright S., Yuille M.R., Houlston R.S. Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia. Leukemia. 13:1999;1497-1500
23. Yuille M.R., Condie A., Hudson C.D., Bradshaw P.S., Stone E.M., Matutes E., Catovsky D., Houlston R.S. ATM mutations are rare in familial chronic lymphocytic leukemia. Blood. 100:2002;603-609
24. Kolomietz E., Al-Maghrabi J., Brennan S., Karaskova J., Minkin S., Lipton J., Squire J.A. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood. 97:2001;3581-3588
25. van der Burg M., Beverloo H.B., Langerak A.W., Wijsman J., van Drunen E., Slater R., van Dongen J.J. Rapid and sensitive detection of all types of MLL gene translocations with a single FISH probe set. Leukemia. 13:1999;2107-2113
26. Rowley J.D., Diaz M.O., Espinosa R. 3rd, Patel Y.D., van Melle E., Ziemin S., Taillon-Miller P., Lichter P., Evans G.A., Kersey J.H., Ward D.C., Domes P.H., Le Beau M.M. Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome. Proc Natl Acad Sci USA. 87:1990;9358-9362
27. Cuthbert G., Thompson K., Breese G., McCullough S., Bown N. Sensitivity of FISH in detection of MLL translocations. Genes Chromosomes Cancer. 29:2000;180-185
28. von Bergh A., Emanuel B., van Zelderen-Bhola S., Smetsers T., van Soest R., Stul M., Vranckx H., Schuuring E., Hagemeijer A., Kluin P. A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias. Genes Chromosomes Cancer. 28:2000;14-22
29. Tomlinson I.P., Strickland J.E., Lee A.S., Bromley L., Evans M.F., Morton J., McGee J.O. Loss of heterozygosity on chromosome 11q in breast cancer. J Clin Pathol. 48:1995;424-428
30. Lee A.S., Seo Y.C., Chang A., Tohari S., Eu K.W., Seow-Choen F., McGee J.O. Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma. Br J Cancer. 83:2000;750-755
31. Wang S.S., Virmani A., Gazdar A.F., Minna J.D., Evans G.A. Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer. Genes Chromosomes Cancer. 25:1999;154-159
32. Baffa R., Negrini M., Mandes B., Rugge M., Ranzani G.N., Hirohashi S., Croce C.M. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res. 56:1996;268-272
33. Davis M., Hitchcock A., Foulkes W.D., Campbell I.G. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res. 56:1996;741-744
34. Evans M.F., Koreth J., Bakkenist C.J., Herrington C.S., McGee J.O. Allelic deletion at 11q23.3-q25 is an early event in cervical neoplasia. Oncogene. 16:1998;2557-2564
35. O'Sullivan M.J., Rader J.S., Gerhard D.S., Li Y., Trinkaus K.M., Gersell D.J., Huettner P.C. Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix. Hum Pathol. 32:2001;475-478
36. Hui A.B., Lo K.W., Leung S.F., Choi P.H., Fong Y., Lee J.C., Huang D.P. Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res. 56:1996;3225-3229
37. Shao J.Y., Huang X.M., Yu X.J., Huang L.X., Wu Q.L., Xia J.C., Wang H.Y., Feng Q.S., Ren Z.F., Ernberg I., Hu L.F., Zeng Y.X. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Anticancer Res. 21:2001;3021-3029